Nastase, Anca
Mandal, Amit
Lu, Shir Kiong
Anbunathan, Hima
Morris-Rosendahl, Deborah
Zhang, Yu Zhi
Sun, Xiao-Ming
Gennatas, Spyridon
Rintoul, Robert C.
Edwards, Matthew
Bowman, Alex
Chernova, Tatyana
Benepal, Tim
Lim, Eric
Taylor, Anthony Newman
Nicholson, Andrew G.
Popat, Sanjay
Willis, Anne E.
MacFarlane, Marion
Lathrop, Mark
Bowcock, Anne M.
Moffatt, Miriam F.
Cookson, William O. C. M.
Funding for this research was provided by:
Libor Fund grant from the UK Department of Health, by the British Lung Foundation and by the Asmarley Foundation
UK Medical Research Council
Article History
Received: 23 March 2021
Accepted: 2 September 2021
First Online: 27 September 2021
Change Date: 21 March 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-022-08800-1
Competing interests
: SP reports honoraria from BMS, Roche, Takea, AstraZeneca, Chugai, Novartis, Pfizer, MSD, EMD Serono, Guardant Health, AbbVie, Boehringer Ingleheim, and Tesaro. All other authors have no competing interests to declare.